ZENOTECH LABORATORIES
|
ZENOTECH LABORATORIES Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.92 | 1.36 | 1.90 | 3.63 | -0.20 |
| CEPS(Rs) | 2.06 | 2.52 | 3.07 | 4.78 | 0.86 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 15.75 | 14.84 | 13.48 | 11.57 | 7.93 |
| Tax Rate(%) | 47.50 | 25.51 | 20.11 | -123.97 | - |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 32.94 | 42.16 | 48.80 | 47.75 | 28.42 |
| EBIT Margin(%) | 24.84 | 27.29 | 34.45 | 30.40 | 1.48 |
| Pre Tax Margin(%) | 24.84 | 27.29 | 34.18 | 27.08 | -5.41 |
| PAT Margin (%) | 13.04 | 20.32 | 27.31 | 60.65 | -5.41 |
| Cash Profit Margin (%) | 29.21 | 37.68 | 44.22 | 79.72 | 23.35 |
| Performance Ratios | |||||
| ROA(%) | 5.43 | 8.68 | 13.37 | 26.45 | -1.42 |
| ROE(%) | 6.01 | 9.60 | 15.15 | 37.26 | -2.48 |
| ROCE(%) | 11.46 | 12.89 | 18.39 | 15.26 | 0.48 |
| Asset Turnover(x) | 0.42 | 0.43 | 0.49 | 0.44 | 0.26 |
| Sales/Fixed Asset(x) | 0.37 | 0.37 | 0.40 | 0.35 | 0.26 |
| Working Capital/Sales(x) | 1.84 | 3.23 | -123.98 | -4.46 | -2.95 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 2.68 | 2.70 | 2.50 | 2.83 | 3.81 |
| Receivable days | 45.38 | 29.38 | 31.20 | 38.59 | 46.02 |
| Inventory Days | - | 7.51 | - | 0.61 | 1.27 |
| Payable days | 1,263.19 | - | - | - | - |
| Valuation Parameters | |||||
| PER(x) | 56.45 | 43.47 | 24.79 | 13.86 | - |
| PCE(x) | 25.20 | 23.45 | 15.31 | 10.54 | 40.76 |
| Price/Book(x) | 3.30 | 3.98 | 3.49 | 4.35 | 4.41 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 6.74 | 8.35 | 6.51 | 8.50 | 10.33 |
| EV/Core EBITDA(x) | 18.45 | 18.71 | 12.67 | 17.18 | 34.15 |
| EV/EBIT(x) | 27.14 | 30.61 | 18.89 | 27.97 | 697.37 |
| EV/CE(x) | 3.02 | 3.77 | 3.36 | 3.80 | 2.70 |
| M Cap / Sales | 7.36 | 8.83 | 6.77 | 8.40 | 9.52 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 5.42 | -3.75 | 16.02 | 62.91 | -13.74 |
| Core EBITDA Growth(%) | -13.70 | -16.34 | 20.44 | 166.48 | -33.12 |
| EBIT Growth(%) | -4.03 | -23.76 | 31.47 | 3,244.31 | -97.15 |
| PAT Growth(%) | -32.36 | -28.37 | -47.76 | 1,925.03 | -111.27 |
| EPS Growth(%) | -32.36 | -28.37 | -47.76 | 1,925.01 | -111.27 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | 0.08 | 0.43 |
| Current Ratio(x) | 2.86 | 1.93 | 0.98 | 0.47 | 0.49 |
| Quick Ratio(x) | 2.86 | 1.87 | 0.98 | 0.47 | 0.49 |
| Interest Cover(x) | - | - | 130.25 | 9.15 | 0.21 |
| Total Debt/Mcap(x) | - | - | - | 0.02 | 0.10 |
Compare Financial Ratios of peers of ZENOTECH LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZENOTECH LABORATORIES | ₹280.7 Cr | 3.1% | -6.3% | -35.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,086.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,616.0 Cr | -1.9% | -1.6% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,361.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹120,713.0 Cr | -1.2% | -2% | 2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,881.0 Cr | -1.2% | 1.5% | -6.1% | Stock Analytics | |
ZENOTECH LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZENOTECH LABORATORIES | 3.1% |
-6.3% |
-35.6% |
| SENSEX | -0.3% |
-1.1% |
7.8% |
You may also like the below Video Courses
